Pegtarazimod

N/A

Report date: 2026/04/08 16:01:28

Base Information

Drug NamePegtarazimod

Drug Alias NamePIC1-01PIC1-dPEG24PA-dPEG24RLS-0071

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionComplement activation inhibitorsComplement C1 inhibitorsInflammation mediator inhibitors +[6]

TargetsComplement C1Peroxidases

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Graft vs Host DiseaseBrain Ischemia +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesGermany +[4]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsGraft vs Host DiseaseBrain IschemiaBrain Diseases +[4]

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Acute Lung InjuryPrecursor Cell Lymphoblastic Leukemia-Lymphoma

ATC CodeN/A